New hope for fighting crippling sleepiness in rare genetic disorder

NCT ID NCT04257929

Summary

This study is testing whether a medication called pitolisant can safely reduce excessive daytime sleepiness in people with Prader-Willi syndrome (PWS), a rare genetic disorder. About 65 patients aged 6 to 65 will receive either the drug or a placebo for 11 weeks, with an option for long-term treatment afterward. Researchers will measure changes in sleepiness, behavior, and caregiver burden to see if the treatment helps.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ann and Robert H Lurie Children's Hospital

    Chicago, Illinois, 60611, United States

  • CTI

    Cincinnati, Ohio, 45212, United States

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Johns Hopkins School of Medicine

    Baltimore, Maryland, 21205, United States

  • Nemours Alfred I duPont Hospital for Children

    Wilmington, Delaware, 19803, United States

  • Rady Children's Hospital - San Diego

    San Diego, California, 92123, United States

  • Road Runner Research

    San Antonio, Texas, 78249, United States

  • Santa Monica Clinical Trials

    Santa Monica, California, 90404, United States

  • Sleep Medicine Specialists of California

    San Ramon, California, 94583, United States

  • Texas Children's Hospital/Baylor College of Medicine

    Houston, Texas, 77030, United States

  • University of Florida College of Medicine

    Gainesville, Florida, 32608, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, 68114, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203, United States

Conditions

Explore the condition pages connected to this study.